Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
European Journal of Pharmacology
|
February 22, 1996
Pharmacological basis for functional selectivity of partial muscarinic receptor agonists
E Heldman, J Barg, A Fisher, et al.
Neuroscience Letters
|
July 31, 1989
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats
A Fisher, R Brandeis, Z Pittel, et al.
Journal of Neurochemistry
|
November 3, 1998
Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretion
R Haring, A Fisher, D Marciano, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
May 13, 2016
Wireless Vital Sign Monitoring in Pregnant Women: A Functionality and Acceptability Study
Adeline Adwoa Boatin, Blair Johnson Wylie, Ilona Goldfarb, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1991
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease
A Fisher, R Brandeis, I Karton, et al.
Advances in Neurology
|
January 1, 1990
AF102B: rational treatment strategy for Alzheimer's disease: recent advances
A Fisher, R Brandeis, I Karton, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
|
January 16, 2020
Pediatric diabetic retinopathy telescreening
Sasha Strul, Yuxi Zheng, Sapna Gangaputra, et al.
Annals of the New York Academy of Sciences
|
December 29, 1995
Dehydroepiandrosterone augments M1-muscarinic receptor-stimulated amyloid precursor protein secretion in desensitized PC12M1 cells
H D Danenberg, R Haring, E Heldman, et al.
Journal of Molecular Neuroscience : MN
|
September 6, 2002
AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease
Abraham Fisher, Rachel Brandeis, Rachel Haring Nira Bar-Ner, et al.
Patient Education and Counseling
|
July 27, 2014
Development and validation of the diabetes adolescent problem solving questionnaire
Shelagh A Mulvaney, Sarah S Jaser, Russell L Rothman, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
European Journal of Pharmacology
|
February 22, 1996
Pharmacological basis for functional selectivity of partial muscarinic receptor agonists
E Heldman, J Barg, A Fisher, et al.
Neuroscience Letters
|
July 31, 1989
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats
A Fisher, R Brandeis, Z Pittel, et al.
Journal of Neurochemistry
|
November 3, 1998
Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretion
R Haring, A Fisher, D Marciano, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
May 13, 2016
Wireless Vital Sign Monitoring in Pregnant Women: A Functionality and Acceptability Study
Adeline Adwoa Boatin, Blair Johnson Wylie, Ilona Goldfarb, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1991
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease
A Fisher, R Brandeis, I Karton, et al.
Advances in Neurology
|
January 1, 1990
AF102B: rational treatment strategy for Alzheimer's disease: recent advances
A Fisher, R Brandeis, I Karton, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
|
January 16, 2020
Pediatric diabetic retinopathy telescreening
Sasha Strul, Yuxi Zheng, Sapna Gangaputra, et al.
Annals of the New York Academy of Sciences
|
December 29, 1995
Dehydroepiandrosterone augments M1-muscarinic receptor-stimulated amyloid precursor protein secretion in desensitized PC12M1 cells
H D Danenberg, R Haring, E Heldman, et al.
Journal of Molecular Neuroscience : MN
|
September 6, 2002
AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease
Abraham Fisher, Rachel Brandeis, Rachel Haring Nira Bar-Ner, et al.
Patient Education and Counseling
|
July 27, 2014
Development and validation of the diabetes adolescent problem solving questionnaire
Shelagh A Mulvaney, Sarah S Jaser, Russell L Rothman, et al.
Page
of 7